Skip to main content
Top
Published in: Drugs & Aging 9/2004

01-08-2004 | Original Research Article

Herbal Supplement Use by Persons Aged Over 50 years in Britain

Frequently Used Herbs, Concomitant Use of Herbs, Nutritional Supplements and Prescription Drugs, Rate of Informing Doctors and Potential for Negative Interactions

Authors: Dr Peter H. Canter, Edzard Ernst

Published in: Drugs & Aging | Issue 9/2004

Login to get access

Abstract

Background

The use of herbal and nutritional supplements by older British people is increasing and despite the risks of adverse effects and negative herb-drug interactions, doctors are often not informed of their use. The number of herbal and nutritional supplements used most frequently by older people, and which particular herbal extracts are used, are unknown. This study aimed to identify how many herbal and nutritional supplements and which herbal extracts are most frequently used by British people >50 years of age, and to identify which herb-drug interactions represent the greatest risk to this age group.

Method

A self-completed survey was promoted through websites and a popular magazine aimed at people >50 years of age.

Results

Respondents (n = 271) used a mean of 2.26 prescription drugs and 5.91 herbal and nutritional supplements, including 2.66 herbal extracts. The use of herbal medicines by older British people frequently involves the use of several herbs, often involves concomitant use with several nutritional supplements, is poorly reported to doctors and places older people at risk of negative herb-drug interactions. The most frequently used herbs and associated risks of negative interactions with prescription drugs are identified.

Conclusions

Older people should be encouraged to report the use of herbs and nutritional supplements to their doctors, and doctors should be provided with comprehensive and up-to-date information about potential herb-drug interactions.
Literature
1.
go back to reference Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 2001; 9: 2–11PubMedCrossRef Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 2001; 9: 2–11PubMedCrossRef
2.
go back to reference Blendon RJ, DesRoches CM, Benson JM, et al. Americans’ views on the use and regulation of dietary supplements. Arch Intern Med 2001; 161: 805–10PubMedCrossRef Blendon RJ, DesRoches CM, Benson JM, et al. Americans’ views on the use and regulation of dietary supplements. Arch Intern Med 2001; 161: 805–10PubMedCrossRef
3.
go back to reference Eskin SB. Dietary supplements and older consumers. Washington, DC. AARP Public Policy Institute, Data Digest 2001; 66: 1–8 Eskin SB. Dietary supplements and older consumers. Washington, DC. AARP Public Policy Institute, Data Digest 2001; 66: 1–8
4.
go back to reference Cohen RJ, Ek K, Pan CX. Complementary and alternative medicine use by older adults: a comparison of self-report and physician chart documentation. J Gerontol A Biol Sci Med Sci 2002; 57(4): M223–7PubMedCrossRef Cohen RJ, Ek K, Pan CX. Complementary and alternative medicine use by older adults: a comparison of self-report and physician chart documentation. J Gerontol A Biol Sci Med Sci 2002; 57(4): M223–7PubMedCrossRef
5.
go back to reference Ernst E, editor. The desktop guide to complementary and alternative medicine: an evidence-based approach. London: Harcourts, 2001 Ernst E, editor. The desktop guide to complementary and alternative medicine: an evidence-based approach. London: Harcourts, 2001
6.
go back to reference Salmond S. Polypharmacy and phytotherapy: issues of herb/drug interactions in the elderly. Aust J Med Herbalism 2002; 14(1): 9–20 Salmond S. Polypharmacy and phytotherapy: issues of herb/drug interactions in the elderly. Aust J Med Herbalism 2002; 14(1): 9–20
7.
go back to reference Guyton AC. Textbook of medical physiology. 8th ed. Philadelphia (PA): WB Saunders & Co, 1991 Guyton AC. Textbook of medical physiology. 8th ed. Philadelphia (PA): WB Saunders & Co, 1991
8.
go back to reference Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001; 52: 587–95PubMedCrossRef Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001; 52: 587–95PubMedCrossRef
9.
go back to reference Lee MSW, Dergal J, Gold J, et al. Use of herbals and potential interactions between herbals and conventional drug therapy in older adults attending a memory clinic. Pharmacoepidemiol Drug Saf 2001; 10: S145 Lee MSW, Dergal J, Gold J, et al. Use of herbals and potential interactions between herbals and conventional drug therapy in older adults attending a memory clinic. Pharmacoepidemiol Drug Saf 2001; 10: S145
10.
go back to reference Bjerrum L, Sogaard J, Hallas J, et al. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract 1999; 49(440): 195–8PubMed Bjerrum L, Sogaard J, Hallas J, et al. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract 1999; 49(440): 195–8PubMed
11.
go back to reference Veehof LJG, Stewart R, Haaijer-Ruskamp FM, et al. Chronic polypharmacy in one-third of the elderly in general practice. Ned Tijdschr Geneeskd 1999; 143(2): 93–7PubMed Veehof LJG, Stewart R, Haaijer-Ruskamp FM, et al. Chronic polypharmacy in one-third of the elderly in general practice. Ned Tijdschr Geneeskd 1999; 143(2): 93–7PubMed
12.
go back to reference Ernst E. Herb-drug interactions: an update. Perfusion 2003; 16: 175–94 Ernst E. Herb-drug interactions: an update. Perfusion 2003; 16: 175–94
13.
go back to reference Yoon SL, Horne CH. Herbal products and conventional medicines used by community-residing older women. J Adv Nurs 2001; 33(1): 51–9PubMedCrossRef Yoon SL, Horne CH. Herbal products and conventional medicines used by community-residing older women. J Adv Nurs 2001; 33(1): 51–9PubMedCrossRef
Metadata
Title
Herbal Supplement Use by Persons Aged Over 50 years in Britain
Frequently Used Herbs, Concomitant Use of Herbs, Nutritional Supplements and Prescription Drugs, Rate of Informing Doctors and Potential for Negative Interactions
Authors
Dr Peter H. Canter
Edzard Ernst
Publication date
01-08-2004
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 9/2004
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200421090-00004

Other articles of this Issue 9/2004

Drugs & Aging 9/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.